No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004–2017, Paris, France)

No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004–2017, Paris, France)

Replacement of fluconazole by echinocandins as the first-line therapy for yeast-related fungemia could have an impact on both the mortality rate and the epidemiology of yeast species responsible for candidemia. We analyzed the individual clinical and microbiological data collected through the active...

Full description

Bibliographic Details
Main Authors: Stéphane Bretagne, Marie Desnos-Ollivier, Karine Sitbon, Olivier Lortholary, Didier Che, Françoise Dromer, Participants of the YEASTS
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Medicine
Subjects:
fungemia
candidemia
epidemiology
hematological malignancy
solid cancer
intensive care unit
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.641965/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.641965/full

Similar Items